Wiehle S - Search Results

1

In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogs.

Kay MA, Landen CN, Rothenberg SR, Taylor LA, Leland F, Wiehle S, Fang B, Bellinger D, Finegold M, Thompson AR, et al. Kay MA, et al. Among authors: wiehle s. Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2353-7. doi: 10.1073/pnas.91.6.2353. Proc Natl Acad Sci U S A. 1994. PMID: 8134398 Free PMC article.

2

Insulin-like growth factor binding protein-6 activates programmed cell death in non-small cell lung cancer cells.

Sueoka N, Lee HY, Wiehle S, Cristiano RJ, Fang B, Ji L, Roth JA, Hong WK, Cohen P, Kurie JM. Sueoka N, et al. Among authors: wiehle s. Oncogene. 2000 Sep 7;19(38):4432-6. doi: 10.1038/sj.onc.1203813. Oncogene. 2000. PMID: 10980619

3

Gene delivery into malignant cells in vivo by a conjugated adenovirus/DNA complex.

Nguyen DM, Wiehle SA, Roth JA, Cristiano RJ. Nguyen DM, et al. Among authors: wiehle sa. Cancer Gene Ther. 1997 May-Jun;4(3):183-90. Cancer Gene Ther. 1997. PMID: 9171937

4

Efficient therapeutic gene delivery after systemic administration of a novel polyethylenimine/DNA vector in an orthotopic bladder cancer model.

Sweeney P, Karashima T, Ishikura H, Wiehle S, Yamashita M, Benedict WF, Cristiano RJ, Dinney CP. Sweeney P, et al. Among authors: wiehle s. Cancer Res. 2003 Jul 15;63(14):4017-20. Cancer Res. 2003. PMID: 12874000

5

Delivery of the p53 tumor suppressor gene into lung cancer cells by an adenovirus/DNA complex.

Nguyen DM, Wiehle SA, Koch PE, Branch C, Yen N, Roth JA, Cristiano RJ. Nguyen DM, et al. Among authors: wiehle sa. Cancer Gene Ther. 1997 May-Jun;4(3):191-8. Cancer Gene Ther. 1997. PMID: 9171938

6

Insulin-like growth factor binding protein-3 inhibits the growth of non-small cell lung cancer.

Lee HY, Chun KH, Liu B, Wiehle SA, Cristiano RJ, Hong WK, Cohen P, Kurie JM. Lee HY, et al. Among authors: wiehle sa. Cancer Res. 2002 Jun 15;62(12):3530-7. Cancer Res. 2002. PMID: 12068000

7

Down-regulation of bcl-2 is associated with p16INK4-mediated apoptosis in non-small cell lung cancer cells.

Kataoka M, Wiehle S, Spitz F, Schumacher G, Roth JA, Cristiano RJ. Kataoka M, et al. Among authors: wiehle s. Oncogene. 2000 Mar 16;19(12):1589-95. doi: 10.1038/sj.onc.1203466. Oncogene. 2000. PMID: 10734319

8

The contribution of poly-L-lysine, epidermal growth factor and streptavidin to EGF/PLL/DNA polyplex formation.

Xu B, Wiehle S, Roth JA, Cristiano RJ. Xu B, et al. Among authors: wiehle s. Gene Ther. 1998 Sep;5(9):1235-43. doi: 10.1038/sj.gt.3300719. Gene Ther. 1998. PMID: 9930325

9

A multifunctional PEI-based cationic polyplex for enhanced systemic p53-mediated gene therapy.

Moffatt S, Wiehle S, Cristiano RJ. Moffatt S, et al. Among authors: wiehle s. Gene Ther. 2006 Nov;13(21):1512-23. doi: 10.1038/sj.gt.3302773. Epub 2006 Jun 8. Gene Ther. 2006. PMID: 16763664

10

Successful in vivo tumor targeting of prostate-specific membrane antigen with a highly efficient J591/PEI/DNA molecular conjugate.

Moffatt S, Papasakelariou C, Wiehle S, Cristiano R. Moffatt S, et al. Among authors: wiehle s. Gene Ther. 2006 May;13(9):761-72. doi: 10.1038/sj.gt.3302721. Gene Ther. 2006. PMID: 16453011

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters